Access cutting-edge thrombotic thrombocytopenic purpura treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Minneapolis location
Access thrombotic thrombocytopenic purpura specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related thrombotic thrombocytopenic purpura treatment provided free
Check if you qualify for this thrombotic thrombocytopenic purpura clinical trial in Minneapolis, MN
No-Cost Study Care
Local to Minneapolis
Convenient for MN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1) or platelet (Part 2) response without plasma exchange during the study. Participants who have an acute attack of iTTP will receive TAK-755 and immunosuppressive therapy during their stay at the hospital until they achieve a clinical response in Part 1 or platelet response in Part 2. Participants wi
Sponsor: Takeda
Yes, this clinical trial (NCT05714969) has an active research site in Minneapolis, MN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for thrombotic thrombocytopenic purpura treatment options in Minneapolis, MN, this clinical trial (NCT05714969) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thrombotic thrombocytopenic purpura specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all thrombotic thrombocytopenic purpura clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Minneapolis — not just this study.
Browse Pulmonary Embolism Trials in Minneapolis →